The Latin America, Middle East and Africa Sacral Nerve Stimulation Market should witness market growth of 7.1% CAGR during the forecast period (2023-2030).
Due to their importance in diagnosing, treating, and monitoring medical disorders, demand for medical equipment stays stable, especially during economic downturns. The rising elderly population and conditions like overactive bladder and urine incontinence further support the continued need for medical devices like sacral nerve stimulators. Technical developments in the sector further boost the medical device industry's resilience to recessions. New technologies are created due to ongoing innovation, which raises productivity, lowers costs, and improves patient outcomes.
By sending carefully timed electrical impulses to the sacral nerves, which regulate the neurological pathways, sacral nerve stimulation (SNS) is a device implanted to manage bladder functions. It is an efficient and secure treatment for patients with fecal and urinary problems. This treatment is advised for patients who did not receive the intended results from therapy or medicine. SNS has a considerable positive impact on improving the impacted people's quality of life. Rising fecal incontinence rates are also anticipated to accelerate the expansion of the market. Being able to affect a person's quality of life and even cause social isolation makes it one of the most damaging conditions.
The Latin America and the Caribbean region is dealing with a severe health issue related to nutrition that has significant economic and social repercussions. The dietary changes are essential: there have been significant increases in the consumption of less healthy, high-sugar, low-nutrient-density foods and beverages, adjustments to eating and snacking habits while away from home, and quick changes toward very high levels of overweight and obesity in people of all ages as well as, in some countries, high rates of stunting. The higher risk of UI is strongly correlated with the high incidence of obesity. These factors are providing growth prospects to the LAMEA region.
The Brazil market dominated the LAMEA Sacral Nerve Stimulation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $10.3 Million by 2030. The Argentina market is estimated to grow at a CAGR of 7.7% during (2023-2030). Additionally, The UAE market would exhibit a CAGR of 6.8% during (2023-2030).
Based on Application, the market is segmented into Urinary & Fecal Incontinence, Chronic Anal Fissure, and Others. Based on Product, the market is segmented into Devices, and Accessories. Based on End-user, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Axonics, Inc., Beijing PINS Medical Co., Ltd., PZMed, Laborie Medical Technologies, Synapse BioMedical, Inc., Johnson and Johnson, LivaNova PLC, Boston Scientific Corporation, and Saluda Medical Pty Ltd.
Due to their importance in diagnosing, treating, and monitoring medical disorders, demand for medical equipment stays stable, especially during economic downturns. The rising elderly population and conditions like overactive bladder and urine incontinence further support the continued need for medical devices like sacral nerve stimulators. Technical developments in the sector further boost the medical device industry's resilience to recessions. New technologies are created due to ongoing innovation, which raises productivity, lowers costs, and improves patient outcomes.
By sending carefully timed electrical impulses to the sacral nerves, which regulate the neurological pathways, sacral nerve stimulation (SNS) is a device implanted to manage bladder functions. It is an efficient and secure treatment for patients with fecal and urinary problems. This treatment is advised for patients who did not receive the intended results from therapy or medicine. SNS has a considerable positive impact on improving the impacted people's quality of life. Rising fecal incontinence rates are also anticipated to accelerate the expansion of the market. Being able to affect a person's quality of life and even cause social isolation makes it one of the most damaging conditions.
The Latin America and the Caribbean region is dealing with a severe health issue related to nutrition that has significant economic and social repercussions. The dietary changes are essential: there have been significant increases in the consumption of less healthy, high-sugar, low-nutrient-density foods and beverages, adjustments to eating and snacking habits while away from home, and quick changes toward very high levels of overweight and obesity in people of all ages as well as, in some countries, high rates of stunting. The higher risk of UI is strongly correlated with the high incidence of obesity. These factors are providing growth prospects to the LAMEA region.
The Brazil market dominated the LAMEA Sacral Nerve Stimulation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $10.3 Million by 2030. The Argentina market is estimated to grow at a CAGR of 7.7% during (2023-2030). Additionally, The UAE market would exhibit a CAGR of 6.8% during (2023-2030).
Based on Application, the market is segmented into Urinary & Fecal Incontinence, Chronic Anal Fissure, and Others. Based on Product, the market is segmented into Devices, and Accessories. Based on End-user, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Axonics, Inc., Beijing PINS Medical Co., Ltd., PZMed, Laborie Medical Technologies, Synapse BioMedical, Inc., Johnson and Johnson, LivaNova PLC, Boston Scientific Corporation, and Saluda Medical Pty Ltd.
Scope of the Study
By Application
- Urinary & Fecal Incontinence
- Chronic Anal Fissure
- Others
By Product
- Devices
- Accessories
By End-user
- Hospitals
- Specialty Clinics
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Axonics, Inc.
- Beijing PINS Medical Co., Ltd.
- PZMed
- Laborie Medical Technologies
- Synapse BioMedical, Inc.
- Johnson and Johnson
- LivaNova PLC
- Boston Scientific Corporation
- Saluda Medical Pty Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Sacral Nerve Stimulation Market by Application
Chapter 5. LAMEA Sacral Nerve Stimulation Market by Product
Chapter 6. LAMEA Sacral Nerve Stimulation Market by End User
Chapter 7. LAMEA Sacral Nerve Stimulation Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Medtronic PLC
- Axonics, Inc.
- Beijing PINS Medical Co., Ltd.
- PZMed
- Laborie Medical Technologies
- Synapse BioMedical, Inc.
- Johnson and Johnson
- LivaNova PLC
- Boston Scientific Corporation
- Saluda Medical Pty Ltd.
Methodology
LOADING...
